Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06YSP
|
|||
Former ID |
DCL000057
|
|||
Drug Name |
AT13387
|
|||
Synonyms |
AT-13387
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
Therapeutic Class |
Anticancer Agents
|
|||
Company |
Astex Therape.
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H31N3O3
|
|||
Canonical SMILES |
CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C
|
|||
InChI |
1S/C24H31N3O3/c1-16(2)20-11-21(23(29)12-22(20)28)24(30)27-14-18-5-4-17(10-19(18)15-27)13-26-8-6-25(3)7-9-26/h4-5,10-12,16,28-29H,6-9,13-15H2,1-3H3
|
|||
InChIKey |
IFRGXKKQHBVPCQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 912999-49-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:140592
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Astex Pharmaceuticals. | |||
REF 2 | Astex Presents Updates on AT13387, its HSP90 Inhibitor, and AT9283, its Multi-Targeted Kinase Inhibitor at the EORTC-NCI-AACR Cancer Conference. Astex. 2008. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.